Balyasny Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6M Buy
233,905
+149,545
+177% +$6.89M 0.03% 871
2025
Q4
$3.78M Sell
84,360
-238,096
-74% -$10M 0.01% 1535
2025
Q3
$12.9M Buy
322,456
+253,587
+368% +$8.93M 0.03% 924
2025
Q2
$2.16M Sell
68,869
-198,273
-74% -$6.47M ﹤0.01% 1691
2025
Q1
$8.96M Buy
267,142
+82,562
+45% +$3.13M 0.02% 977
2024
Q4
$7.24M Buy
184,580
+100,382
+119% +$4.15M 0.02% 1108
2024
Q3
$3.31M Sell
84,198
-149,137
-64% -$6.01M 0.01% 1447
2024
Q2
$9.1M Buy
233,335
+32,061
+16% +$1.28M 0.02% 926
2024
Q1
$8.66M Buy
201,274
+185,423
+1,170% +$8.53M 0.02% 993
2023
Q4
$730K Buy
+15,851
New +$560K ﹤0.01% 1810
2023
Q1
Sell
-162,828
Closed -$6.42M 3260
2022
Q4
$6.42M Buy
162,828
+15,473
+11% +$563K 0.02% 921
2022
Q3
$5.32M Buy
+147,355
New +$5.3M 0.02% 958

Other funds holding XENE